It's Never Black and White?: Racial and Ethnic Differences in Molluscum Contagiosum and Eczema

Mollenol Research14th Jul 2025

Racial and ethnic disparities in dermatological conditions, particularly molluscum contagiosum and atopic dermatitis (eczema), reveal significant patterns in prevalence, severity, and access to care across different communities in the United States and globally. The evidence shows that both conditions disproportionately affect minority populations, particularly Black and Hispanic children, with varying patterns of disease manifestation and healthcare utilization.

Atopic Dermatitis (Eczema) Disparities

Prevalence and Severity Patterns

Black children demonstrate consistently higher rates and more severe presentations of atopic dermatitis. Research consistently shows that Black children are 1.7 to 2.1 times more likely to receive an atopic dermatitis diagnosis compared to White children^[1]. A comprehensive study of 4,016 infants found that 37.0% of Black infants were diagnosed with AD compared to only 17.9% of White infants, representing an odds ratio of 2.6^[2]. Hispanic children also show elevated rates, with 24.1% prevalence compared to the 17.9% baseline for White children^[2].

Severity disparities are particularly pronounced. Black children with AD are more than twice as likely, and Hispanic children are more than 1.5 times as likely, to have severe AD compared to White children^[1]. These disparities extend beyond childhood, with adult prevalence showing Black/African American adults at 8.5%, White adults at 7.7%, Asian adults at 6.5%, and Hispanic adults at 4.8%^[3].

Healthcare Access and Treatment Disparities

Significant disparities exist in healthcare utilization and treatment access. Studies reveal that non-Hispanic White infants receive more prescriptions from their pediatricians than Hispanic infants with eczema^[4]^[5]. Additionally, non-Hispanic Black and Asian infants wait longer to see a dermatologist after receiving prescriptions compared to White patients^[4]. Emergency department utilization patterns show dramatic differences: Hispanic children have 3.71 times more emergency department visits than non-Hispanic White children, while Black children have 1.52 times more visits^[6].

Prescription patterns reveal treatment disparities. Research demonstrates that compared to White patients, Black and Hispanic patients are less likely to be prescribed nonsteroidal topicals, and non-White patients are less likely to be prescribed systemic medications^[7]. This suggests potential inadequacies in treatment intensity for minority populations despite their higher disease severity.

Specialist Care Access

Access to specialized care shows concerning patterns. Only 46.7% of Black children with atopic dermatitis are evaluated by allergists, compared to 69% of White children^[8]. Healthcare utilization trends show that only White children demonstrated significantly increasing trends in being "seen by a medical specialist," while all other minority race subgroups had stagnant trends^[9].

Molluscum Contagiosum Patterns

General Prevalence and Demographics

Molluscum contagiosum affects approximately 6 million people in the United States annually, with the highest incidence in children aged 1-14 years^[10]^[11]^[12]. The condition has a 5-11% prevalence rate in children, with the greatest incidence in individuals aged one to 14 years old^[10].

Racial and Ethnic Considerations in Molluscum

Limited specific racial data exists for molluscum contagiosum prevalence. However, interesting patterns emerge from international research. A study from Israel examining ethnic disparities found that 95.2% of pediatric molluscum cases were Jewish and only 4.8% were Arab, despite Arabs comprising 21.1% of the population^[13]^[14]. This suggests potential differences in healthcare-seeking behavior or access patterns across ethnic groups.

Giant molluscum cases show specific population patterns. Case series have documented eight cases of giant molluscum contagiosum in healthy, immunocompetent African immigrant children in Columbus, Ohio^[15]^[16], suggesting potential genetic or environmental factors that may influence disease presentation in specific populations.

Anecdotal and Community Evidence

Anecdotal evidence suggests facial molluscum lesions may be associated with specific populations. Studies from Nigeria indicate anecdotal evidence associating facial lesions with HIV-related immunodeficiency^[17], though this association is primarily relevant to immunocompromised populations rather than general racial differences.

Community-acquired molluscum demonstrates typical viral transmission patterns regardless of racial background, with transmission occurring through direct contact, shared towels, and swimming pools^[18]^[19].

Underlying Factors Contributing to Disparities

Socioeconomic Determinants

Socioeconomic factors significantly influence dermatological care access. Research indicates that socioeconomic variables such as residential areas and household income significantly influence disease outcomes^[20]. However, the relationship between socioeconomic status and atopic dermatitis shows complex patterns, with some studies finding mixed associations between pediatric AD and socioeconomic status, with AD positively associated with parental education^[20].

Insurance status creates significant barriers. Studies show that Medicaid coverage is highest among Hispanics (46%) and Blacks (27%) compared to private insurance being highest among Asians (82%) and Whites (70%)^[21]. Additionally, 22.6% of patients reported that they or a household member had been unable to get medicine or healthcare in the past year, with this being reported by 32.2% of Black/African American patients^[22].

Healthcare System Barriers

Structural racism affects healthcare delivery. Research emphasizes that genetic polymorphisms associated with increased risk of AD are less common among Black people, suggesting that social determinants rather than genetic factors drive observed disparities^[1]. This finding challenges biological explanations and points to systemic factors.

Provider diversity and cultural competency gaps exist. The dermatology workforce lacks diversity, with significant underrepresentation of minority physicians. Geographic disparities compound these issues, with rural and underserved areas having limited access to dermatological care^[23]^[24].

Recognition and Diagnosis Challenges

Diagnostic challenges exist for conditions affecting skin of color. Medical education traditionally lacks adequate representation of dermatological conditions in diverse skin tones. Unfortunately, textbooks from which medical students learn often don't contain images of AD in Black and Hispanic patients^[25], leading to potential misdiagnosis or delayed diagnosis.

Geographic and Rural-Urban Disparities

Rural populations face additional barriers to dermatological care. Research shows clear evidence of poorer outcomes for patients with dermatological conditions living in regional, rural and remote areas with limited access to specialist dermatology services^[26]. Dermatologist density increases most in rural areas but the gap between metropolitan and other areas continues to widen^[23].

Urban versus rural patterns affect both conditions. Studies indicate that urban areas have higher prevalence of AD^[20], while rural areas face longer wait times and reduced access to specialist care^[23].

Research Gaps and Anecdotal Evidence

Limited anecdotal evidence exists for specific racial patterns in molluscum. While systematic research on racial differences in molluscum contagiosum remains limited, community reports and clinical observations suggest potential variations in presentation and healthcare-seeking behavior across different ethnic groups^[15]^[16]^[14].

Community-based observations indicate potential disparities. Healthcare providers report varying patterns of presentation and treatment-seeking behavior across different communities, though these observations require more systematic documentation and research.

Implications and Future Directions

Addressing these disparities requires multifaceted approaches. Recommendations include increasing diversity among healthcare providers, improving cultural competency training, expanding access to care, and addressing systemic barriers that perpetuate health inequities^[27]^[28].

Research priorities should focus on understanding mechanisms. Future studies need to distinguish between genetic, environmental, and social determinants of these disparities while developing targeted interventions to improve outcomes for affected communities^[1]^[29].

The evidence clearly demonstrates that both molluscum contagiosum and eczema exhibit significant racial and ethnic disparities in prevalence, severity, and access to care. While systematic research on molluscum remains more limited compared to eczema, the available data suggests important patterns that warrant further investigation. Addressing these disparities requires comprehensive approaches that tackle both individual healthcare access issues and broader systemic factors contributing to health inequities.

⁂

Racial Disparities in Molluscum Contagiosum and Eczema Prevalence: Black vs White Communities

Based on the comprehensive research from the previous conversation and current evidence, there are notable differences in how molluscum contagiosum and eczema (atopic dermatitis) affect Black and White communities. The disparities are particularly pronounced for eczema, while molluscum contagiosum data shows more limited racial-specific information.

Atopic Dermatitis (Eczema) Disparities

Prevalence Differences

Black children demonstrate significantly higher rates of atopic dermatitis compared to White children. Multiple studies consistently show that Black children are 1.7 to 2.1 times more likely to receive an atopic dermatitis diagnosis than White children[1]. A comprehensive study of 4,016 infants found striking differences: 37.0% of Black infants were diagnosed with AD compared to only 17.9% of White infants, representing an odds ratio of 2.6[2].

The prevalence differences continue across age groups. Among adults, Black/African American adults show an 8.5% prevalence compared to White adults at 7.7%[3]. Recent data indicates that Black patients had the sharpest increase in eczema prevalence over time, jumping from 10.1% to 18.4%, while White patients rose from 7.3% to 11.3%[3].

Severity and Clinical Presentation

Black children with AD experience more severe disease presentations. Research shows that Black children with AD are more than twice as likely to have severe AD compared to White children[1]. In clinical studies, Black patients demonstrated statistically more severe lichenification (skin thickening) compared to White patients across multiple body regions including head and neck, trunk, upper extremities, and lower extremities[4].

Distinct clinical features vary by race. Among AD clinical features, the prevalence of facial erythema was significantly lower among Black compared with White patients (prevalence ratio = 0.38)[4]. However, Black patients reported significantly higher mean pruritus (itching) compared to White patients[4].

Healthcare Access and Treatment Disparities

Provider Access Patterns

Significant disparities exist in specialist care access. Only 46.7% of Black children with atopic dermatitis are evaluated by allergists, compared to 69% of White children[5]. Healthcare utilization trends show that only White children demonstrated significantly increasing trends in being "seen by a medical specialist," while all other minority race subgroups had stagnant trends[5].

Treatment prescription patterns reveal concerning disparities. Black patients with AD were less likely to receive several key medications including desonide, tacrolimus, pimecrolimus, crisaborole, and dupilumab compared to White patients[6]. Research demonstrates that compared to White patients, Black patients are less likely to be prescribed nonsteroidal topicals, and non-White patients are less likely to be prescribed systemic medications[5].

Emergency Department Utilization

Emergency department usage patterns differ dramatically by race. Black children have 1.52 times more emergency department visits than non-Hispanic White children for eczema-related issues[5]. These patterns suggest potential inadequacies in routine dermatological care access.

Molluscum Contagiosum Patterns

General Prevalence Data

Overall molluscum contagiosum affects approximately 6 million people in the United States annually with a 5-11% prevalence rate in children[7][8]. The condition shows the highest incidence in children aged 1-14 years[7].

Limited Racial-Specific Data

Specific racial prevalence data for molluscum contagiosum remains limited. Historical studies from the 1990s found that 93% of patients diagnosed with molluscum contagiosum were white[9]. However, more recent comprehensive analysis shows that non-Hispanics (82.9%) and Caucasians (91.0%) made up the majority of visitors in pediatric molluscum cases, with dermatologists seeing a higher percentage of Caucasian patients (95%) compared to pediatricians (84%)[10][11].

International studies suggest potential ethnic variations. Research from Israel examining ethnic disparities found that 95.2% of pediatric molluscum cases were Jewish and only 4.8% were Arab, despite Arabs comprising 21.1% of the population[12]. This disproportionate representation suggests potential differences in healthcare-seeking behavior or access patterns across ethnic groups.

Healthcare Utilization Patterns

Provider specialty patterns differ by race. Dermatologists saw a higher percentage of Caucasian patients (95% vs 84%) and patients with private insurance (83% vs 73%) compared to pediatricians for molluscum treatment[11]. This suggests potential access disparities in specialist dermatological care for minority populations.

Underlying Factors Contributing to Disparities

Socioeconomic and Structural Factors

Genetic factors do not explain the disparities in eczema. Research emphasizes that genetic polymorphisms associated with increased risk of AD are less common among Black people, suggesting that social determinants rather than genetic factors drive observed disparities[1][13]. Filaggrin (FLG) mutations, the strongest genetic risk factor for AD development, are detected in up to 50% of European and 27% of Asian AD patients, but are six times less common in subjects of African descent[13].

Insurance and access barriers create significant disparities. Studies show that Medicaid coverage is highest among Black patients (27%) compared to private insurance being highest among Whites (70%)[5]. Additionally, 22.6% of patients reported being unable to get medicine or healthcare in the past year, with this being reported by 32.2% of Black/African American patients[5].

Healthcare System Barriers

Diagnostic challenges exist for conditions affecting skin of color. Medical education traditionally lacks adequate representation of dermatological conditions in diverse skin tones. Textbooks from which medical students learn often don't contain images of AD in Black and Hispanic patients, leading to potential misdiagnosis or delayed diagnosis[5].

Provider diversity gaps affect care quality. The dermatology workforce lacks diversity, with significant underrepresentation of minority physicians[5]. This can impact cultural competency and understanding of disease presentations in different racial groups.

Key Differences Summary

Eczema shows clear racial disparities with Black children experiencing:

7-2.1 times higher prevalence than White children
More severe disease presentations
Reduced access to specialist care
Different treatment prescription patterns
Higher emergency department utilization

Molluscum contagiosum data is more limited but suggests:

Historically higher representation among White patients in healthcare utilization
Potential access disparities in specialist dermatological care
Limited systematic research on racial differences in prevalence

The evidence clearly demonstrates that structural and social determinants of health, rather than genetic factors, primarily drive these disparities. Addressing these differences requires comprehensive approaches that tackle both individual healthcare access issues and broader systemic factors contributing to health inequities in dermatological care.

Using Mollenol for molluscum

Mollenol’s Efficacy and User-Friendliness

Mollenol emerges as a highly effective, natural, and user-friendly treatment for molluscum contagiosum. While conventional methods continue to hold validity, Mollenol’s accessibility and gentle action harmoniously meet the requirements of a diverse range of age groups. As an increasing number of individuals gravitate towards natural remedies, Mollenol presents a promising solution, ensuring satisfactory outcomes for patients afflicted with the distressing presence of molluscum bumps.

Free newsletter to help you understand your skin issue.